Cited by 1,036Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans

Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., Crowther, R. A.·1996·Nature

DOI 10.1038/383550a0

Open this paper in CoChat — free account

Abstract

The paired helical filament (PHF) is the major component of the neurofibrillary deposits that form a defining neuropathological characteristic of Alzheimer's disease. PHFs are composed of microtubule-associated protein tau, in a hyperphosphorylated state. Hyperphosphorylation of tau results in its inability to bind to microtubules and is believed to precede PHF assembly. However, it is unclear whether hyperphosphorylation of tau is either necessary or sufficient for PHF formation. Here we show that non-phosphorylated recombinant tau isoforms with three microtubule-binding repeats form paired helical-like filaments under physiological conditions in vitro, when incubated with sulphated glycosaminoglycans such as heparin or heparan sulphate. Furthermore, heparin prevents tau from binding to microtubules and promotes microtubule disassembly. Finally, we show that heparan sulphate and hyperphosphorylated tau coexist in nerve cells of the Alzheimer's disease brain at the earliest known stages of neurofibrillary pathology. These findings, with previous studies which show that heparin stimulates tau phosphorylation by a number of protein kinases, indicate that sulphated glycosaminoglycans may be a key factor in the formation of the neurofibrillary lesions of Alzheimer's disease.

Integrity signals

Registry

Crossref · 10.1038/383550a0

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau
Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134
Self-citation
Tau proteins of alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms
Goedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,122
Self-citation
Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease.
Wischik, C. M., Novak, M., Thøgersen, H. C., Edwards, P. C., Runswick, M. J., Jakes, R., Walker, J. E., Milstein, C., Roth, M., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4506 · Cited by 939
Self-citation
Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization.
Goedert, M., & Jakes, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07870.x · Cited by 929
Self-citation
Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding
Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903
Self-citation
A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads
Braak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 769
Tau protein and the neurofibrillary pathology of Alzheimer's disease
Goedert, M. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90078-z · Cited by 721
Self-citation

Flagged first, then by citations

Show all 32 references

Research works printed but not linked: 2

Brandt, R., Lee, G., Teplow, D. B., Shalloway, D. & Abdel-Ghany, M. J. Biol. Chem. 269, 11176–11782 (1994).
Snow, A. D. et al. Am. J. Pathol. 137, 1253–1270 (1990).

Sorted by citations

Items 201–300 of 1,000

Understanding the Kinetic Roles of the Inducer Heparin and of Rod-like Protofibrils during Amyloid Fibril Formation by Tau Protein
Ramachandran, G., & Udgaonkar, J. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.271874 · Cited by 143
Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies
Strang, K. H., Croft, C. L., Sorrentino, Z. A., Chakrabarty, P., Golde, T. E., & Giasson, B. I. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.815357 · Cited by 124
A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114
Crystal, A., Giasson, B. I., Crowe, A., Kung, M., Zhuang, Z., Trojanowski, J. Q., & Lee, V. M. ‐. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01949.x · Cited by 138
Examining the mechanisms that link β-amyloid and α-synuclein pathologies
Marsh, S. E., & Blurton-Jones, M. M. (2012) · Alzheimer s Research & Therapy · doi:10.1186/alzrt109 · Cited by 140
Pseudophosphorylation and Glycation of Tau Protein Enhance but Do Not Trigger Fibrillization in Vitro
Necula, M., & Kuret, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405527200 · Cited by 140
New Insights Into Drug Discovery Targeting Tau Protein
Soeda, Y., & Takashima, A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.590896 · Cited by 136
Fundamentals of cross-seeding of amyloid proteins: an introduction
Ren, B., Zhang, Y., Zhang, M., Liu, Y., Zhang, D., Gong, X., Feng, Z., Tang, J., Chang, Y., & Zheng, J. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01871a · Cited by 139
The Opitz syndrome gene product, MID1, associates with microtubules
Schweiger, S., Foerster, J., Lehmann, T., Suckow, V., Muller, Y. A., Walter, G., Davies, T., Porter, H. J., van Bokhoven, H., Lunt, P. W., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.2794 · Cited by 134
Amyloid accomplices and enforcers
Alexandrescu, A. T. (2004) · Protein Science · doi:10.1110/ps.04887005 · Cited by 137
Tau gene mutations and their effects
Goedert, M. (2005) · Movement Disorders · doi:10.1002/mds.20539 · Cited by 134
Self-citation
Pick's disease associated with the novel Tau gene mutation K369I
Neumann, M., Schulz‐Schaeffer, W., Crowther, R. A., Smith, M. J., Spillantini, M. G., Goedert, M., & Kretzschmar, H. A. (2001) · Annals of Neurology · doi:10.1002/ana.1223 · Cited by 134
Self-citation
Formaldehyde induces hyperphosphorylation and polymerization of Tau protein both in vitro and in vivo
Lü, J., Jun-Ye, M. I. A. O., Su, T., Liu, Y., & He, R. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.028 · Cited by 132
Aberrant Tau Phosphorylation by Glycogen Synthase Kinase-3β and JNK3 Induces Oligomeric Tau Fibrils in COS-7 Cells
Sato, S., Tatebayashi, Y., Akagi, T., Chui, D.-H., Murayama, M., Miyasaka, T., Planel, E., Tanemura, K., Sun, X., Hashikawa, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202241200 · Cited by 135
Nonsaturable Binding Indicates Clustering of Tau on the Microtubule Surface in a Paired Helical Filament-like Conformation
Ackmann, M., Wiech, H., & Mandelkow�, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002590200 · Cited by 138
Glycosaminoglycans and β-amyloid, prion and tau peptides in neurodegenerative diseases
Díaz‐Nido, J., Wandosell, F. G., & Ávila, J. (2002) · Peptides · doi:10.1016/s0196-9781(02)00068-2 · Cited by 131
Hyperphosphorylation determines both the spread and the morphology of tau pathology
Hu, W. H., Zhang, X., Tung, Y. C., Xie, S.-T., Liu, F., & Iqbal, K. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.01.014 · Cited by 137
Cofactors are essential constituents of stable and seeding-active tau fibrils
Fichou, Y., Lin, Y., Rauch, J. N., Vigers, M., Zeng, Z., Srivastava, M., Keller, T. J., Freed, J. H., Kosik, K. S., & Han, S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810058115 · Cited by 128
Tau filaments in neurodegenerative diseases
Goedert, M. (2018) · FEBS Letters · doi:10.1002/1873-3468.13108 · Cited by 127
Self-citation
Axonal Degeneration Induced by Targeted Expression of Mutant Human Tau in Oligodendrocytes of Transgenic Mice That Model Glial Tauopathies
Higuchi, M., Zhang, B., Forman, M. S., Yoshiyama, Y., Trojanowski, J. Q., & Lee, V. M. ‐. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2691-05.2005 · Cited by 133
Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility
Sahara, N., Lewis, J. M., Deture, M. A., McGowan, E. M., Dickson, D. W., Hutton, M., & Yen, S.-H. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01241.x · Cited by 127
Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations
Liu, Q., Smith, M. A., Ávila, J., DeBernardis, J. F., Kansal, M. M., Takeda, A., Zhu, X., Nunomura, A., Honda, K., Moreira, P. I., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.11.005 · Cited by 129
Self-citation
Nucleation-dependent Tau Filament Formation
Congdon, E. E., Kim, S., Bonchak, J., Songrug, T., Anastasios Matzavinos, A., & Kuret, J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800247200 · Cited by 126
Amyloid-β pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo
Vergara, C., Houben, S., Suain, V., Yilmaz, Z., Decker, R. D., Dries, V. V., Boom, A., Mansour, S., Leroy, K., Ando, K., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1953-5 · Cited by 131
Liquid–liquid phase separation of tau: From molecular biophysics to physiology and disease
Rai, S. K., Savastano, A., Singh, P., Mukhopadhyay, S., & Zweckstetter, M. (2021) · Protein Science · doi:10.1002/pro.4093 · Cited by 129
Pathways of tau fibrillization
Kuret, J., Chirita, C. N., Congdon, E. E., Kannanayakal, T. J., Li, G., Necula, M., Yin, H., & Zhong, Q. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.016 · Cited by 135
The Effect of Glycosaminoglycans (GAGs) on Amyloid Aggregation and Toxicity
Iannuzzi, C., Irace, G., & Sirangelo, I. (2015) · Molecules · doi:10.3390/molecules20022510 · Cited by 124
Chronic Aluminum Intake Causes Alzheimer's Disease: Applying Sir Austin Bradford Hill's Causality Criteria
Walton, J. R. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132204 · Cited by 126
Microglia in Alzheimer’s Disease in the Context of Tau Pathology
Perea, J. R., Bolós, M., & Ávila, J. (2020) · Biomolecules · doi:10.3390/biom10101439 · Cited by 134
Analysis of Tau Phosphorylation and Truncation in a Mouse Model of Human Tauopathy
Delobel, P., Lavenir, I., Fraser, G. M., Ingram, E., Holzer, M., Ghetti, B. F., Spillantini, M. G., Crowther, R. A., & Goedert, M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070627 · Cited by 124
Self-citation
Human Tau Isoforms Assemble into Ribbon-like Fibrils That Display Polymorphic Structure and Stability
Wegmann, S., Jung, Y. J., Chinnathambi, S., Mandelkow, E., Mandelkow�, E., & Müller, D. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.145318 · Cited by 129
Phosphorylated tau and the neurodegenerative foldopathies
Kosik, K. S., & Shimura, H. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.10.011 · Cited by 124
Heat Shock Proteins and Amateur Chaperones in Amyloid-Beta Accumulation and Clearance in Alzheimer’s Disease
Wilhelmus, M. M. M., de Waal, R. M. W., & Verbeek, M. M. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0029-7 · Cited by 125
Phosphorus Dendrimers Affect Alzheimer’s (Aβ1–28) Peptide and MAP-Tau Protein Aggregation
Wasiak, T., Йонов, М., Nieznański, K., Nieznańska, H., Klementieva, O. L., Granell, M., Cladera, J., Majoral, J., Caminade, A., & Klajnert‐Maculewicz, B. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2005627 · Cited by 125
Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets
Lee, V. M.-Y., Brunden, K. R., Hutton, M., & Trojanowski, J. Q. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006437 · Cited by 122
Deamidation and Isoaspartate Formation in Smeared Tau in Paired Helical Filaments
Watanabe, A., Takio, K., & Ihara, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7368 · Cited by 124
Effect of Pseudophosphorylation and Cross-linking by Lipid Peroxidation and Advanced Glycation End Product Precursors on Tau Aggregation and Filament Formation
Kuhla, B., Haase, C., Flach, K., Lüth, H.-J., Arendt, T., & Münch, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609521200 · Cited by 119
Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease
Jicha, G. A., Berenfeld, B., & Davies, P. J. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990315)55:6 · Cited by 119
Role of ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative disorders
Layfield, R., Cavey, J. R., & Lowe, J. S. (2003) · Ageing Research Reviews · doi:10.1016/s1568-1637(03)00025-4 · Cited by 118
Alzheimer's disease: β‐Amyloid protein and tau
Morishima‐Kawashima, M., & Ihara, Y. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10355 · Cited by 118
Different distribution of phosphorylated tau protein isoforms in Alzheimer's and Pick's diseases
Sergeant, N., David, J.-P., Lefranc, D., Vermersch, P., Wattez, A., & Delacourte, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00859-4 · Cited by 117
Pathogenesis of the Tauopathies
Goedert, M., & Spillantini, M. G. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9593-4 · Cited by 126
Self-citation
Alzheimer disease
Nussbaum, J. M., Seward, M. E., & Bloom, G. S. (2013) · Prion · doi:10.4161/pri.22118 · Cited by 128
Transgenic zebrafish model of neurodegeneration
Tomasiewicz, H. G., Flaherty, D. B., Soria, J., & Wood, J. G. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10451 · Cited by 117
Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4‐hydroxy‐2‐nonenal
Pérez, M., Cuadros, R., Smith, M. A., Perry, G. L., & Ávila, J. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02323-1 · Cited by 116
Self-citation
Polymerization of tau peptides into fibrillar structures. The effect of FTDP‐17 mutations
Arrasate, M., Pérez, M., Armas-Portela, R., & Ávila, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00210-0 · Cited by 118
Neurofibrillary tangle‐like tau pathology induced by synthetic tau fibrils in primary neurons over‐expressing mutant tau
Guo, J., & Lee, V. M. ‐. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.051 · Cited by 117
Phosphorylation of tau at Ser214 mediates its interaction with 14‐3‐3 protein: implications for the mechanism of tau aggregation
Sadik, G., Tanaka, T., Kato, K., Yamamori, H., Begum, N. N., Morihara, T., & Takeda, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05716.x · Cited by 114
Loss of perineuronal net N-acetylgalactosamine in Alzheimer’s disease
Baig, S., Wilcock, G. K., & Love, S. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1060-2 · Cited by 112
Tau and Axonopathy in Neurodegenerative Disorders
Higuchi, M., Lee, V. M.-Y., & Trojanowski, J. Q. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:2:2:131 · Cited by 134
Therapeutic strategies for the treatment of tauopathies: Hopes and challenges
Khanna, M. R., Kovalevich, J., Lee, V. M. ‐., Trojanowski, J. Q., & Brunden, K. R. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.006 · Cited by 116
Crowded Cell-like Environment Accelerates the Nucleation Step of Amyloidogenic Protein Misfolding
Zhou, Z., Fan, J.-B., Zhu, H., Shewmaker, F. P., Yan, X., Chen, X., Chen, J., Xiao, G., Guo, L., & Liang, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.002832 · Cited by 114
Galectin-8–mediated selective autophagy protects against seeded tau aggregation
Falcon, B., Noad, J., McMahon, H. T., Randow, F., & Goedert, M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.809293 · Cited by 119
Self-citation
Protein misfolding and amyloid nucleation through liquid–liquid phase separation
Mukherjee, S., Poudyal, M., Dave, K., Kadu, P., & Maji, S. K. (2024) · Chemical Society Reviews · doi:10.1039/d3cs01065a · Cited by 117
Tau biology, tauopathy, traumatic brain injury, and diagnostic challenges
Castellani, R. J., & Perry, G. (2019) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180721 · Cited by 110
Discoveries of Tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: A personal historical perspective
Iqbal, K., & Grundke, I. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s325 · Cited by 113
Glial Tau Pathology in Neurodegenerative Diseases: Their Nature and Comparison with Neuronal Tangles
Ikeda, K., Akiyama, H., Arai, T., & Nishimura, T. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00034-7 · Cited by 112
Interactions of Amyloidogenic Proteins
Giasson, B. I., Lee, V. M. ‐., & Trojanowski, J. Q. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:49 · Cited by 106
Longitudinal stability of CSF tau levels in Alzheimer patients
Sunderland, T., Wolozin, B. L., Galasko, D., Levy, J., Dukoff, R. A., Bahro, M., Lasser, R. A., Motter, R. N., Lehtimäki, T. J., & Seubert, P. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00143-2 · Cited by 107
Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation
Guix, F. X., ILL‐Raga, G., Bravo, R., Nakaya, T., Fabritiis, G. D., Coma, M., Miscione, G. P., Villà-Freixa, J., Suzuki, T., Fernàndez‐Busquets, X., et al. (2009) · Brain · doi:10.1093/brain/awp023 · Cited by 107
Truncation of Tau selectively facilitates its pathological activities
Gu, J., Xu, W., Jin, N., Li, L., Zhou, Y., Chu, D., Gong, C., Iqbal, K., & Liu, F. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012587 · Cited by 108
HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer’s disease-related tau pathology
Sepulveda-Diaz, J. E., Naini, S. M. A., Huynh, M. B., Ouidja, M. O., Yanicostas, C., Chantepie, S., Villares, J., Lamari, F., Jospin, E., Kuppevelt, T. H. V., et al. (2015) · Brain · doi:10.1093/brain/awv056 · Cited by 108
Oligodendroglial tau filament formation in transgenic mice expressing G272V tau
Götz, J., Tolnay, M., Barmettler, R., Chen, F., Probst, A., & Nitsch, R. M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01604.x · Cited by 107
Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders
Janke, C., Beck, M., Stahl, T., Holzer, M., Brauer, K., Bigl, V., & Arendt, T. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00079-0 · Cited by 104
Variations in filament conformation dictate seeding barrier between three- and four-repeat Tau
Dinkel, P. D., Siddiqua, A., Huynh, H., Shah, M., & Margittai, M. (2011) · Biochemistry · doi:10.1021/bi2004685 · Cited by 104
Formation of aberrant phosphotau fibrillar polymers in neural cultured cells
Pérez, M., Hernández, F., Gómez‐Ramos, A., Smith, M. A., Perry, G. L., & Ávila, J. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02794.x · Cited by 103
Self-citation
Prion-like Spreading in Tauopathies
Ayers, J. I., Giasson, B. I., & Borchelt, D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.04.003 · Cited by 106
Pathological Changes of Tau Related to Alzheimer’s Disease
Chu, D., & Liu, F. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00457 · Cited by 106
Quantitative Characterization of Heparin Binding to Tau Protein
Zhu, H., Fernández, C., Fan, J.-B., Shewmaker, F. P., Chen, J., Minton, A. P., & Liang, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035691 · Cited by 102
Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides
Awasthi, A., Matsunaga, Y., & Yamada, T. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.08.001 · Cited by 102
Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening
Crowe, A., Huang, W., Ballatore, C., Johnson, R. L., Hogan, A. L., Huang, R., Wichterman, J., McCoy, J. G., Huryn, D. M., Auld, D. S., et al. (2009) · Biochemistry · doi:10.1021/bi9006435 · Cited by 104
In vitro 0N4R tau fibrils contain a monomorphic β-sheet core enclosed by dynamically heterogeneous fuzzy coat segments
Dregni, A. J., Mandala, V. S., Wu, H., Elkins, M. R., Wang, H. K., Hung, I., DeGrado, W. F., & Hong, M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906839116 · Cited by 98
Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
Visanji, N. P., Lang, A. E., & Kovács, G. G. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0172-x · Cited by 102
Molecular crowding and RNA synergize to promote phase separation, microtubule interaction, and seeding of Tau condensates
Hochmair, J., Exner, C., Franck, M., Dominguez‐Baquero, A., Diez, L., Brognaro, H., Kraushar, M. L., Mielke, T., Radbruch, H., Kaniyappan, S., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021108882 · Cited by 101
Sulfates Dramatically Stabilize a Salt-Dependent Type of Glucagon Fibrils
Pedersen, J. S., Flink, J. M., Dikov, D., & Otzen, D. E. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.070912 · Cited by 100
Neurodegeneration: diseases of the cytoskeleton?
McMurray, C. T. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400764 · Cited by 99
Rapid Tau Aggregation and Delayed Hippocampal Neuronal Death Induced by Persistent Thrombin Signaling
Suo, Z., Wu, M., Citron, B. A., Palazzo, R. E., & Festoff, B. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301406200 · Cited by 99
Hydration water mobility is enhanced around tau amyloid fibers
Fichou, Y., Schirò, G., Gallat, F., Laguri, C., Moulin, M., Combet, J., Zamponi, M., Haertlein, M., Picart, C., Mossou, E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422824112 · Cited by 99
From tau phosphorylation to tau aggregation: what about neuronal death?
Buée, L., Troquier, L., Burnouf, S., Bélarbi, K., der Jeugd, A. V., Ahmed, T., Fernández-Gómez, F.-J., Caillierez, R., Grosjean, M., Bégard, S., et al. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380967 · Cited by 99
Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration
Sahara, N., Maeda, S., & Takashima, A. (2008) · Current Alzheimer Research · doi:10.2174/156720508786898442 · Cited by 99
Baicalein suppresses Repeat Tau fibrillization by sequestering oligomers
Sonawane, S. K., Balmik, A. A., Boral, D., Ramasamy, S., & Chinnathambi, S. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108119 · Cited by 98
Link Between DYRK1A Overexpression and Several-Fold Enhancement of Neurofibrillary Degeneration With 3-Repeat Tau Protein in Down Syndrome
Węgiel, J., Kaczmarski, W., Barua, M., Kuchna, I., Nowicki, K., Wang, K.-C., Wegiel, J., Mazur‐Kolecka, B., Frackowiak, J., Mazur‐Kolecka, B., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318202bfa1 · Cited by 98
Structure and Mechanism of Action of Tau Aggregation Inhibitors
Cisek, K. K., Cooper, G., Huseby, C. J., & Kuret, J. (2014) · Current Alzheimer Research · doi:10.2174/1567205011666141107150331 · Cited by 98
Polyanions and the Proteome
Jones, L. S., Yazzie, B., & Middaugh, C. R. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r400008-mcp200 · Cited by 97
Cryo-EM structure of RNA-induced tau fibrils reveals a small C-terminal core that may nucleate fibril formation
Abskharon, R. N. N., Sawaya, M. R., Boyer, D. R., Cao, Q., Nguyen, B. A., Cascio, D., & Eisenberg, D. S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119952119 · Cited by 97
Electrostatically Driven Complex Coacervation and Amyloid Aggregation of Tau Are Independent Processes with Overlapping Conditions
Lin, Y., Fichou, Y., Zeng, Z., Hu, N. Y., & Han, S. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00627 · Cited by 93
Hierarchical chemical determination of amyloid polymorphs in neurodegenerative disease
Li, D., & Liu, C. (2021) · Nature Chemical Biology · doi:10.1038/s41589-020-00708-z · Cited by 97
TRIM11 protects against tauopathies and is down-regulated in Alzheimer’s disease
Zhang, Z., Harischandra, D. S., Wang, R., Ghaisas, S., Zhao, J. Y., McMonagle, T. P., Zhu, G., Lacuarta, K. D., Song, J., Trojanowski, J. Q., et al. (2023) · Science · doi:10.1126/science.add6696 · Cited by 95
Alzheimer's Disease-like Paired Helical Filament Assembly from Truncated Tau Protein Is Independent of Disulfide Crosslinking
Al‐Hilaly, Y. K., Pollack, S. J., Vadukul, D. M., Citossi, F., Rickard, J. E., Simpson, M. C., Storey, J. M. D., Harrington, C. R., Wischik, C. M., & Serpell, L. C. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.09.007 · Cited by 93
Physico-Pathologic Mechanisms Involved in Neurodegeneration: Misfolded Protein-Plasma Membrane Interactions
Shrivastava, A. N., Aperia, A. C., Melki, R., & Triller, A. (2017) · Neuron · doi:10.1016/j.neuron.2017.05.026 · Cited by 96
Microtubule-Affinity Regulating Kinase (MARK) Is Tightly Associated with Neurofibrillary Tangles in Alzheimer Brain: A Fluorescence Resonance Energy Transfer Study
Chin, J., Knowles, R. B., Schneider, A., Drewes, G., Mandelkow, E., & Hyman, B. T. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.11.966 · Cited by 95
Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation
Stewart, K. L., & Radford, S. E. (2017) · Biophysical Reviews · doi:10.1007/s12551-017-0271-9 · Cited by 95
Tau aggregation into fibrillar polymers: taupathies
Ávila, J. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01676-8 · Cited by 94
Structural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics
Varani, L. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.3.710 · Cited by 94
Ferritin is associated with the aberrant tau filaments present in progressive supranuclear palsy.
Pérez, M., Valpuesta, J., de Garcini, E. M., Quintana, C., Arrasate, M., Carrascosa, J. L., Rábano, A., de Yébenes, J. G., & Ávila, J. (1998) · Europe PMC (PubMed Central) · Cited by 94
Tau-directed drug discovery for alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors
Brunden, K. R., Ballatore, C., Crowe, A., Smith, Lee, V. M.-Y., & Trojanowski, J. Q. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.031 · Cited by 93
Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
Kwon, S., Iba, M., Kim, C., & Masliah, E. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00853-2 · Cited by 97
The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer’s Disease
Calfío, C., González, A., Singh, S. K., Rojo, L. E., & Maccioni, R. B. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200443 · Cited by 95
AßT Amyloidogenesis: Unique, or Variation on a Systemic Theme
Kisilevsky, R., Fraser, P. E., & Benson, M. D. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709082674 · Cited by 92
Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease
Norlund, M. A., Lee, J. M., Zainelli, G. M., & Muma, N. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02179-4 · Cited by 93
Glycan Determinants of Heparin-Tau Interaction
Zhao, J., Huvent, I., Lippens, G., Eliezer, D., Zhang, A., Li, Q., Tessier, P., Linhardt, R. J., Zhang, F., & Wang, C. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.01.024 · Cited by 87

Authors: Goedert, M., Jakes, R., Spillantini, M. G., Hasegawa, M., Smith, M. J., & Crowther, R. A.
Affiliations: MRC Laboratory of Molecular Biology (GB)
ORCID: Goedert, M.
Hasegawa, M.
Smith, M. J.
Crowther, R. A.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1996-10
Volume: 383
Issue: 6600
Pages: 550-553
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/383550a0
OpenAlex: W1994282166
Cited by: 1,036
References: 32
Citations by year: 2026: 29 · 2025: 35 · 2024: 43 · 2023: 47 · 2022: 57 · 2021: 50 · 2020: 43 · 2019: 47 · 2018: 50 · 2017: 48 · 2016: 26 · 2015: 27 · 2014: 20 · 2013: 42 · 2012: 30
FWCI: 27.47
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: tau protein, paired helical filaments, Alzheimer's disease, neurofibrillary tangles, sulfated glycosaminoglycans, heparin, heparan sulfate, tau hyperphosphorylation, microtubule binding, microtubule disassembly, tau isoforms, neurofibrillary pathology
MeSH terms: Alzheimer Disease, Escherichia coli, Heparin, Heparitin Sulfate, Heparan Sulfate, Hippocampus, Humans, Neurofibrils, Phosphorylation, Protein Binding, Recombinant Proteins, tau Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks